Filip Scheperjans

Neurologist / CEO at Helsinki University Hospital and NeuroInnovation Ltd.

Filip Scheperjans, MD, PhD, studied medicine at the University of Düsseldorf (Germany) and gained international experience as a visiting student in London, New York and Helsinki. Now living in Finland he works as attending neurologist and clinical researcher at the Department of Neurology at Helsinki University Hospital.

Currently, his main focus in on the role of microbiota in Parkinson’s disease and his group was the first to demonstrate microbiome community structure alterations in Parkinson’s disease. For his groundbreaking work in this field he was awarded the Uschi Tschabitscher Prize for Young Neurologists by the European Academy of Neurology in 2014. His work led to granted and pending patents related to the use of gut microbiota in the diagnosis and treatment of Parkinson’s disease.

scheperjans_filip_hires_Helsinki_University Hospital_Gut_Week_Barcelona_Microbiome_1

Case Study: What do we know about the role of the Microbiota-Gut-Brain-Axis in Parkinson’s Disease?

Other Speakers from the Gut Week Summit

Wouter de Jonge

Professor of Neurogastroenterology at AMC

Ruth Ann Luna

Assistant Professor at Baylor College of Medicine

Pierre Lestage

Chief Executive Officer at NeribiOm, France